city of Pergamos in Asia minor where there lived a man named Claudius Galen who had more influence on medicine than any other individual for the next 1500 years (figure 1). It is astonishing today to think of the impact that Galen had on medicine. With knowledge gained from dissecting apes and other animals that were killed by the Roman gladiators, Galen demonstrated that the heart is made up of muscle and he described the presence and movement of blood in the arteries. He made many important contributions to medicine, but several of his erroneous views were documented as truth by the Church and accepted as dogma for 1500 years. It was not until the Renaissance that anyone dared challenge his authority. Galen believed that the liver, rather than the heart, was the central organ of the circulation (figure 2). He viewed blood in arteries as ebbing and flowing with the heart's pulsation. While his view of the circulation was erroneous, Galen was correct in suggesting that blood moved from one side of the heart to the other. He was faced with the problem of describing how blood passed from the right to the left side of the heart. He proposed the hypothesis that the interventricular septum contained small pores that allowed the blood to pass from the right side to the left where it entered the arteries to pass out to the tissues.2' Humility was not one of Galen's attributes. He once said that if anyone desired to become famous, one had only to accept what he had accepted.
Medical knowledge quickly declined between the time of Galen and that of the Renaissance. The Renaissance rekindled man's desire for discovery and exploration. Not only were there courageous explorers who sailed the oceans, there also came a new breed of scientists and physicians interested in studying the mysteries of life. The spirit of medical inquiry was recaptured.
During the Renaissance, Leonardo da Vinci, who lived from 1452 to 1519, illustrated the close relationship between art which remain today at Windsor Castle. Leonardo had problems drawing the coronary vessels since "they are surrounded by waxy fat." This was possibly why some early anatomists had failed to observe the coronary arteries. Leonardo demonstrated the origin of the coronary vessels, and his drawings indicate changes with aging. In his drawing The Anatomy ofthe Old Man, the vessels appear as tortuous. Leonardo wrote, "vessels in the elderly, through the thickenings of the tunics, restrict the transit of the blood," and "the artery and the vein in the aged which extend between the spleen and the liver, acquires so thick a covering that it contracts the passage of blood....' This is one of the earliest descriptions of the changes of arteriosclerosis. In the Anatomy of the Old Man Leonardo describes, "debility through lack of blood and deficiency of the artery which nourishes the heart and the other lower members." This reference apparently refers to a diminished blood flow through the aorta.2 Leonardo's illustrations of the coronary arteries are exquisite and very precise, and these, along with his descriptions, added much to the limited knowledge of the age.
Another great collection of medical illustrations is found in the book called De Humani Corporis Fabrica Libri Septem, published in 1555 by Andreas Vesalius (figure 4). Andreas, born in 1514, went to Paris when he was 18 years old to study anatomy (figure 5). At this time, the study of anatomy was greatly hampered by a 14th century edict of Pope Boniface VII that prohibited the dismemberment of corpses. Vesalius obtained his medical degree in Paris in 1537 and subsequently carried out his studies at the University of Padua, where he became a professor and discovered more than 200 errors of Galen. His lectures at Padua might be described as mob scenes. There was hysterical shouting and cheering as he was violently attacked by pro-Galenic forces. Vesalius wrote of one of his patients whom he called "the most noble and learned Dominus de Imersel," a member of the court of Charles V. Vesalius described a "sad feeling and pain in the heart of poor Imersel," explaining that, "in the left ventricle of his heart we found almost two pounds of glandulous flesh, whereby the heart distended like a belly around this flesh." This man "was, before his death, in a persistant melancholic and wakeful state, his pulse being really astonishingly unequal and changeable, manifestly demonstrating the contraction of the artery."2 Vesalius made the inference that this "sad feeling and pain" was related to heart disease, an idea that figure 6 ). It is important to realize, though, that as much a landmark as was Harvey's discovery, it was not made in isolation. Great breakthroughs in medical knowledge are almost always dependent upon other discoveries and the intellectual climate of the time. Harvey benefited from the great advances in knowledge about the human body that occurred during the Renaissance and that were centered in Northern Italy. The intellectual lineage of Harvey's predecessors was as follows: Andreas Vesalius was a professor of anatomy at Padua, and was the teacher of Columbo, who in turn was the teacher both of Fabricus and of Andreas Cesalpino. Fabricus was also a professor of anatomy in Padua; he discovered the valves in the veins, and was the teacher of William Harvey.3 Andrea Cesalpino of Arezzo lived from approximately 1525 to 1603 and accurately described the circulation in several of his writings, one of which was published in 1571, and which actually used the words 'blood circulation" (figure 7). Most of his scientific observations, unfortunately, were buried in long philosophical and religious treatises, one of which was devoted to the subject of demons. In about 1592, Cesalpino was called to Rome to serve as physician to the Pope. He also became Professor of Medicine at the University of Rome during this period. Cesalpino's description of the circulation was not nearly as clear CIRCULATION is... and precise as Harvey's, nor did it have the experimental evidence produced by Harvey to support its claims. Harvey closely observed the pumping action of the heart. His major achievement was in establishing the concept that the circulation was a closed system, and he was the first to establish the principal features of the circulation on a quantitative basis. 4' It was more than 200 years later that William Heberden described angina pectoris as a manifestation of heart disease (figure 8). Heberden, who lived from 1710 to 1801, read his article, "Some Account of a Disorder of the Breast" at the College of Physicians in 1768, and published it in 1772. Heberden was greatly admired and respected in his time for his high standards of scholarship and for his integrity. He stated that he made his observations in "the chambers of the sick"; he was not affiliated with a hospital. His interpretations were very conservative and today he would be considered slow to publish. While there certainly were inferences about angina pectoris by earlier writers, including Harvey, Heberden did not appear to have knowledge of these. He described heart pain on exertion as follows, "they who are afflicted with it, are seized while they are walking (especially if it be uphill, and soon after eating) with a painful and most disagreeable sensation in the breast, which seems as if it would extinguish life if it were to increase or to contin-Vol. 72, No. 1, July 1985 an individual he called "Doctor Anonymous" and published it 13 years later in 1785. Doctor Anonymous was a 52-year-old physician-patient who had a tendency toward obesity. He first experienced symptoms at age 47 when he had chest pain radiating down the left arm upon walking. "I attributed it to an obstruction in the circulation, sensations which to me seemed to indicate a sudden death." He described these symptoms in a letter to Heberden. After he died, Doctor Anonymous' serum was described as "thick like cream"; this possibly was the earliest description of hyperlipidemia. The doctor died suddenly after suffering an attack of angina pectoris. Heberden described the higher incidence of angina pectoris in men versus women, and he singled out angina pectoris from other types of heart conditions. His great contribution was in his emphasis of clinical description, rather than anatomical findings. 2 Another interesting case involves the examination performed by the famous surgical pathologist John Hunter in 1775. Upon dissection of the coronary arteries Hunter found "(they) were transformed into one piece of bone . . the blood had not in the least coagulated." The patient described here was a 63-year-old man who had complaints 3 or 4 years before his death. Hunter wrote, "In a sudden and violent transport of anger, he fell down and expired immediately." This description illustrates the importance of emotion, stress, and anger in precipitating coronary death.2 Hunter himself suffered from angina pectoris and reportedly died suddenly after a violent argument with a hospital colleague. 3 The Quaker physician, John Fothergill (1 712-1780) gave interesting advice concerning the prevention of coronary disease and arteriosclerosis. On the first appearance of symptoms, he advised the patient to adopt a plan of restricted food, which "might greatly retard the progress of the disorder, and to restrain excesses of passion and anxiety, which perhaps contribute more to the increase of this disease than a combination of all other causes." Thus, Fothergill forecast the role of diet and psychosocial factors in the etiology of coronary heart disease. 2 While Heberden related angina pectoris to disease of the heart, it remained for Edward Jenner ( 1749-1 832), the discoverer of the smallpox vaccine, to make the essential link between angina pectoris and disease of the coronary arteries. Jenner wrote a letter to Heberden in 1778 about a patient who had died of the angina pectoris. He described the coronary artery of a deceased doctor as being ossified and like a "fleshy tube" that did not appear to have any connection with the 12 coat of the artery, and that may have represented a recanalized thrombus. He added that "the heart . was loaded with fat and the vessels were concealed in that substance. "2 With these observations of ossification or calcification of the coronary arteries and of a blood clot within an artery, we are getting closer to a more precise description of the pathogenesis of angina pectoris and myocardial infarction. The first clear description of arteriosclerosis was presented by the Italian surgeon and anatomist Antonio Scarpa, who lived from 1752 to 1832 (figure 9). In his book, Sull Aneurisma, Riflession: ed Osservazioni Anatomico-chirurgiche (figure 10) he described the cause of aneurysm as "slow, morbid ulcerated, steatomatous, fungus, squamous degeneration of the internal coat of the artery." He further wrote, "these diseases, which sometimes soften the substance of the heart and dispose it to ulceration and rupture, are likewise common in the arteries."2 Here is a description of a fatty, ulcerated lesion, and a statement that the disorganization of the internal coat is responsible for the development of arteriosclerosis. Both the concepts of fatty infiltration and of intimal involvement are present in Scarpa's description. Scarpa predicted correctly that the process causing arteriosclerosis is a long-term one, and that it has unknown causes.
The term "arteriosclerosis" was coined in 1833 by arteriosclerosis. Virchow adopted the word "thrombosis, which actually dates back to Galen, who de scribed a vascular obstruction due to thrombosis. Virchow noted three conditions necessary for thrombosis to occur: (1) an increase in the coagulability of the blood, ( sels. Virchow thought that the atheroma represented a chronic inflammation of the intima, and believed intimal damage to be a very early step in the development of an atheroma. He believed that cholesterol accumulation occurred late in the sequence of events, and he observed gelatinous swelling of the intima preceding the formation of an atherosclerotic plaque.2 Baron Karl von Rokitansky was one of the leading pathologists of his day. His Manual of Pathological Anatomy, published in the 1840s, ran counter to Virchow's view that inflammation was an important factor in the etiology of atherosclerosis. Instead, Rokitansky proposed that atherosclerosis developed in the intima because of the formation of many small blood clots that were eventually converted into scar tissue. Rokitansky's view was that "the deposit is an endogenous product derived from the blood, and for the most part from fibrin.7"2
The establishment of coronary thrombosis as a diagnosable clinical entity had to await the 20th century. We usually credit James Herrick with the first description in the article, "Clinical Features of Sudden Ob struction of the Coronary Arteries," published in the Journal ofthe American Medical Association in 1912. This report clearly related obstruction of the coronary arteries to chest pain and, in some instances, sudden death. Herrick described a sudden coronary blockage and emphasized the clinical recognition of coronary obstruction during a patient's life. Herrick said "the publication arroused no interest. It fell like a dud. Recognizing the radical nature of the view I held, I doggedly kept at the subject, doing what I called 'missionary work' I hammered away at the topic. When in 1918, I showed lantern slides and electrocardiograms of coronary obstruction, physicians in America and later Europe woke up to the diagnosis, which was later to become a household word translated by the layman into 'heart attack. ' 
"2
While Herrick generously credited earlier workers' contributions, he was unaware that two Russian clinicians from Kiev had published a similar description of the diagnosis of coronary artery thrombosis in 1910. W. P. Obrastzow and N. D. Straschesko described three cases in great detail. In two of these cases, diagnosis was made while the patient was still living. The two Russian doctors emphasized the role of physical exertion and emotional stress as precipitating events. They used the term thrombosis, while Herrick used the term coronary obstruction. 2 The earliest descriptions of experimental arteriosclerosis are also attributable to Russian scientists. In 1908, A. I. Ignatovski demonstrated the relationship between diet and atherosclerosis by feeding milk and egg yolks to rabbits to induce severe atherosclerosis.6 N. W. Stuckey, in 1912, found that while a diet high in egg yolk and brain caused arterial lesions, one containing sunflower seed and fish oil did not. N. Anichkov and S. Chalatov performed a classical experiment of cholesterol feeding in 1913 by adding pure cholesterol to a rabbit's diet to produce atherosclerosis. A very interesting summary of their work and of the research, carried out at the Anichkov school of pathology in Leningrad, was published in 1958 by A. L. Myasnikov. 2 The 20th century brought many important contributions to the study of arteriosclerosis. These include the discovery of lipoproteins by Macheboef, the important discoveries concerning diet and atherosclerosis, the elaboration of the role of the endothelial injury hypothesis, the role of platelets, and the proliferative nature of plaque development.7 Also important was the discovery of the relationship of risk factors, including plasma lipoproteins, hypertension, cigarette smoking, and diabetes, to the development and progression of coronary artery disease.
The study of atherosclerotic lesions continues to be an integral part of coronary heart disease research. Atherosclerotic lesions have been subdivided into fatty streaks, fibrous plaques, and complicated lesions. The proliferation of smooth muscle cells within the intima, the accumulation of cholesterol and cholesteryl esters, and the elaboration of connective tissue are accepted pathologic hallmarks of atherosclerosis. Injury to the endothelial cells may be provoked by hypercholesterolemia, hypertension, cigarette smoking, and diabetes. In hypercholesterolemic primates, blood monocytes can be seen adhering to the surface of endothelial cells. These cells may migrate into the intima, accumulate intracellular cholesterol, and become macrophages.9 10 Fatty streaks, which were described by Stary'12 in the first decade of life, consist of mainly fat-filled macrophages and smooth muscle cells within the intima. If the endothelial lining becomes damaged, platelets from the blood adhere to the subendothelial matrix. A growth factor, originally discovered in platelets and called the platelet-derived growth factor (PDGF), may be released from platelets and from damaged endothelial cells, from macrophages, and possibly by altered smooth muscle cells under certain conditions. This growth factor stimulates the growth and proliferation of smooth muscle cells. This entire atherosclerotic process may represent an exaggerated form of wound healing. Thromboxane A2 released from platelets is toxic to the arterial wall, while prostacyclin or PGI2, 14 produced by the endothelial cell, is protective. An angiogenesis growth factor, present in many tissues of the body, can stimulate endothelial cell growth, and could lead to capillary proliferation, manifested by an increase in the vasa vasorum, in the region of an atherosclerotic plaque.
Where do we go from here? What do we have to look forward to; what are the future directions of arteriosclerosis research in the 80s and the 90s? The first plenary session of this year's annual meeting dealt with the question where do we stand with the cholesterol or LDL (low-density lipoprotein) hypothesis? Several studies reported in the past year have shown that the lowering of cholesterol by diet or drugs will decrease the rate of progression of an atherosclerotic plaque. The Coronary Primary Prevention Trial'3 14 has provided the most conclusive evidence to date that lowering cholesterol and LDL will decrease coronary heart disease risk, defined as the sum of nonfatal and/or fatal myocardial infarctions. What we now need is a more effective and convenient way of lowering LDL and plasma cholesterol. The development of more potent drugs and the perfection of noninvasive methods for measuring the progression of arteriosclerosis should make it possible to test various treatment modalities more quickly and with fewer subjects.
There should be safe and effective ways of lowering LDL cholesterol by 50% or more by the end of this decade. One approach to reducing LDL is by stimulating the activity of the hepatic receptors that bind the lipoprotein and remove it from the circulation, an approach that is derived from the work of Brown and Goldstein. Figure 1 1 shows the inverse relationship between the relative number of LDL receptors in the liver and the concentration of plasma LDL. The Coronary Primary Prevention Trial used cholestyramine, which increases the activity of hepatic LDL receptors. The combination of a bile acid sequestrant with a safe and effective inhibitor of hydroxymethylglutaryl coenzyme A reductase is one possible approach. Another potential approach is to devise ways of manipulating the activity of macrophage lipoprotein receptors. We do not know yet whether lipoprotein uptake by these receptors is harmful or protective to the arterial wall, but this question should be answerable.
Two other questions that demand answers are: Is it beneficial to raise high-density lipoprotein (HDL), and what are the long-term affects of doing so? Drugs that increase the activity of hepatic lipase, for example, might enhance cholesterol removal by the liver, decreasing the plasma level of HDL. Undoubtedly, if raising HDL concentrations does turn out to be beneficial, the pharmaceutical industry will devise new ways of accomplishing this. At the present time, the methods available include physical exercise, estrogen therapy, alcohol in moderate amounts, and drugs such as nicotinic acid and gemfibrozil. The use of estrogen would be restricted to postmenopausal females while moderate alcohol consumption has been shown to raise HDL in sedentary males, but not in exercising males or premenopausal females. In addition, alcohol has been found to raise the level of HDL3, while the HDL2 subfraction is thought to be associated with a decreased coronary risk. Because of the toxic effects of alcohol and the social hazards associated with its use, I cannot justify recommending alcohol consumption to the general public to prevent coronary disease, as popular as this approach might be with many of our patients.
More than likely, substances will be discovered that protect the arterial wall without exerting their primary effect on plasma lipids and lipoproteins. We do not yet know the precise cause of atherosclerosis. Once we do, we will be in a much stronger position to devise rational methods of treatment and prevention. Potential ways of protecting the arterial wall may be through reducing intracellular calcium overload with the use of slowchannel calcium blockers or other calcium antagonists. Other strategies are the development of agents that interfere with endogenous promoters of atherosclerosis such as PDGF or other growth factors, or through the manipulation of the metabolites of the arachidonic acid pathway. Specific vasodilator action is an appealing approach that might take advantage of the reactivity of blood vessel wall. The coronary arteries have a considerable ability to dilate. The blood flow of the coronary artery system might be increased severalfold, producing a potentially enormous coronary artery reserve, if we had the drugs to produce a specific coronary dilation.
In the next 20 years we will probably see less open heart surgery, more percutaneous transluminal coronary angioplasty, and more selective angioplasty with a multivessel approach. More heart transplants and heart-lung transplants will be done. Completely implantable heart support devices should be developed over the next two decades. Pacemakers will be programmed to intervene in potentially fatal arrhythmias. We should be able to diagnose arteriosclerosis much earlier in life with an array of diagnostic procedures ranging from B mode ultrasound to nuclear magnetic resonance, positron-emission tomographic scanning, and the use of fiber optics to look inside vessels.
Laser sources will be tested for their ability to remove atherosclerotic blockage at selected sites as an interoperative procedure. The percutaneous application of laser therapy is a more distant possibility. Various approaches to thrombolysis will be tested, including the use of tissue-type plasminogen activator. An ultimate goal is production of a completely synthetic substance that could promote the removal of tissue cholesterol, including that in the arterial wall, and facilitate its transport to the liver, where the cholesterol may be excreted as sterol or bile acid. The use of synthetic peptides mimicking the proteins of HDL represents an approach of this kind.
In the next 20 years, we will surely see more emphasis and effort given to prevention, with particular emphasis on the young. Prevention should become a part of every health education, science, and biology class.
Perhaps the greatest impact can be made by altering the habits and beliefs of our young people. It is much more difficult to affect the lifestyle of the adult population, which will probably be more reluctant to give up the dietary and other habits to which they have become accustomed. It is possible to have restaurants that provide foods that are both a culinary delight and healthy for your heart. Government and volunteer organizations such as the American Heart Association must play a leadership role in the future if effective prevention is to become a reality.
In the field of arteriosclerotic disease, we continue to see changes in the patterns of disease. As the incidence of syphilitic and rheumatic heart disease has greatly diminished, so should the incidence of coronary heart disease by the close of this century. The coronary care unit of the year 2000 may be as deserted as the tuberculosis sanitorium of today. I believe that the disappearance of arteriosclerosis will require a major new breakthrough in therapy, but I believe that there is a good likelihood of this happening. Cardiovascular surgeons will not be put out of business by the Vol. 72, No. 1, July 1985 15 disappearance of atherosclerosis, but they will be replacing worn out vessels rather than doing bypasses.
After all forms of heart disease, lung disease, and cancer have been cured, we will be left to face the process of aging. An English actuary by the name of Benjamin Gompertz made an interesting statement in this regard. Gompertz lived in Northampton and published his findings about 1825. His writings lay dormant until recent years when investigators in the field of cancer biology found that his mathematical formula could predict the growth of cancer cells during certain stages of their development. The curve plotted by this equation shows that beyond a certain age the risk of death increases geometrically15 ( figure 12) . The implication is that if one reaches a certain age, beyond that point the likelihood of dying becomes more a function of having reached that age than it is of any specific disease entity. Thus, aging itself becomes the critical factor and if you do not die of one thing, you will die of another.
One of the exciting avenues of the future is the intersection of different disease entities at the level of basic science; for example, pulmonary disease and arteriosclerosis may merge at the level of the study of changes in collagen, endothelial cells, or prostaglandins. Studies of arteriosclerosis and neoplasms could have in common investigations of the proliferation of the capillary, as in the vasa vasorum around an athero- sclerotic plaque, and of the role of the PDGF or other growth factors in stimulating cell growth. Cancer and arteriosclerosis may also merge in the study of the cell surface and of cell membranes. For example, the ratio of cholesterol to phospholipid and the degree of saturation and unsaturation of phospholipid in the membrane of a cell may alter the fluidity of the membrane, its physiologic properties, and its likelihood of the formation of a malignant clone or an atherosclerotic plaque.
In this panoramic view of arteriosclerosis, I have tried briefly to span a time just under 2000 years. I am optimistic about the future of medicine in the United States, and am especially optimistic over the prospects of conquering arteriosclerosis. With the applications of molecular biology and of basic science to the problems of arteriosclerosis and cardiovascular disease, I believe that we are poised to make discoveries over the next 50 years that rival the importance of those of the Italian Renaissance. At that remarkable time, some of the finest minds of Europe, including William Harvey, came to the universities of Northern Italy for advanced education. The social atmosphere was cosmopolitan and the intellectual climate was receptive of new ideas, new discoveries, and change. It was here that the term Renaissance man was most appropriately applied. William Harvey stood at the crossroads of a great breakthrough in understanding the circulation. The beauty of his work is an inspiration to all of us as we contemplate the past, study the present, and dream of the future.
